Express Scripts outlines new programs

In a Express Scripts Holding Co. (NASDAQ:ESRX) CMO Steven Miller outlined three new efforts to help control drug costs, including treatments for diabetes and inflammatory/autoimmune diseases. The PBM is discussing the programs with clients this week at its annual

Read the full 397 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE